MiMedx Group, Inc. (MDXG)
NASDAQ
Closed
Oct 23, 2026
Day's Range
3.8552 wk Range
3.03Overview - MDXG - MiMedx Group, Inc.
Key Statistics
Valuation
Enterprise Value
585.39M
P/E (Trailing)
117.25
P/E (Forward)
34.31
PEG Ratio
-0.48
Price / Sales (TTM)
1.92
Price / Book
3.16
EV / EBITDA
28.68
Profitability
Gross Margin
68.95%
Profit Margin
1.75%
Operating Margin
-28.69%
Return on Assets
1.91%
Return on Equity
2.88%
Ownership
Shares Outstanding
145.72M
Float
114.78M
Short % of Shares Outstanding
8.11%
Held by Insiders
2.14%
Held by Institutions
77.80%
Price stats
Beta
1.17
50-Day Avg
4.52
200-Day Avg
4.43
Dividends
Payout Ratio
0.00%
Analyst Consensus
5 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MDXG - MiMedx Group, Inc.
Peers - MDXG - MiMedx Group, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- MDXGNASDAQMiMedx Group, Inc.684.43MMarket Cap-43.07%52-week change117.25P/E (Trailing)1.75%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.13BMarket Cap-20.35%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.01BMarket Cap+16.49%52-week change18.23P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - MDXG - MiMedx Group, Inc.
About
MiMedx Group, Inc. is a healthcare company focused on regenerative biologics and advanced wound care products. MiMedx Group, Inc. develops, manufactures, and markets placental tissue allografts and other biomaterial products used in wound care, surgical, burn, orthopedic, spine, sports medicine, ophthalmic, and dental…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
